MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Blink Recovery Pattern and Somatosensory Evoked Blink Reflex in patients with Parkinsonism syndromes

    S. Tandra, R.M. Mridula, R. Borgohain (Hyderabad, India)

    Objective: To assess somatosensory evoked blink reflex (SSEBR) and Blink Reflex recovery curve (BRrc) in patients with Parkinsonism Syndromes and compare it with normal control…
  • 2018 International Congress

    Diffusion tensor imaging of olfactory tract in Parkinson’s disease

    P. Nigro, N. Tambasco, A. Chiappiniello, S. Simoni, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: We investigated the possible relationships among olfactory impairment and alterations in diffusion tensor imaging (DTI) of olfactory tracts, comparing a cohort of patients with…
  • 2018 International Congress

    Clinical evaluation of insomnia in Parkinson’s disease and its effect on the quality of life of patients

    M. Salokhiddinov. (Tashkent, Uzbekistan)

    Objective: Assessment of the incidence of insomnia, its association with motor, neuropsychiatric disorders, clarifying the impact on the quality of life of patients with PD…
  • 2018 International Congress

    Association between sleep duration and subsequent risk of Parkinson´s disease and survival: Data from NEDICES study

    R. López-Blanco, A. Sánchez-Ferro, J. Benito-León, F. Bermejo-Pareja, E. de Pablo-Fernández (Alcalá de Henares, Spain)

    Objective: To evaluate whether sleep duration (i) is associated with a subsequent risk of Parkinson’ disease (PD); (ii) affects mortality rates in PD patients, using…
  • 2018 International Congress

    “Frequency of autonomic and cardiovascular abnormalities in Mexican patients with early Parkinson’s disease”

    J. Balderas, A. Gonzalez (Mexico City, Mexico)

    Objective: To determine the frequency of dysautomic disorders and structural cardiac abnormalities in patients with early PD. Background: Parkinson´s disease (PD) is a neurodegenerative disease…
  • 2018 International Congress

    Factors Associated with Non-adherence to Pharmacotherapy in Patients with Parkinson´s Disease Who Take Three and More Daily Doses of Dopaminergic Drugs

    I. Straka, M. Škorvánek, M. Grofik, K. Danterová, M. Minár, J. Benetin, P. Valkovič (Bratislava, Slovakia)

    Objective: Study was aimed to detect extent of adherence to pharmacotherapy in patients with Parkinson´s disease (PD) who take three and more daily doses of…
  • 2018 International Congress

    Screening performance of abbreviated versions of the UPSIT smell test

    T. Joseph, S. Auger, L. Peress, D. Rack, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare the screening performance of existing abbreviated (4-12 item) versions of the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and to identify…
  • 2018 International Congress

    Lottery choice task as a detect tool for PD patients with pathological gambling

    W. Liu, R. Wu, J. Goh (Hualien, Taiwan)

    Objective: We aim to develop a tool lack of stigma to detect patients' impulse control problems. Background: Dopaminergic medication is current major treatment for Parkinson's…
  • 2018 International Congress

    Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease

    A. Batla, U. Uchiyama, S. Simeoni, C. Melbourne, M. Baldwin, L. DeMin, G. Gonzales, C. Haslam, M. Pakzad, S. Islam, S. Eriksson, K. Bhatia, J. Panicker (London, United Kingdom)

    Objective: To evaluate the effect of melatonin on nocturia. Background: Nocturia is one of the commonest non motor symptoms in Parkinsons’ disease (PD), and has…
  • 2018 International Congress

    Efficacy of liquid sinemet on non-motor symptoms in Parkinson’s disease

    M. Danoudis, R. Iansek, C. Boon (Cheltenham, Australia)

    Objective: To investigate the short term effect of liquid sinemet on the non-motor symptoms of people with advanced Parkinson’ disease (PD) who experience complex motor…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley